Relay Therapeutics, Inc. - Common Stock (RLAY)

Relay Therapeutics is a biotechnology company focused on transforming the drug discovery process through its innovative approach that combines advanced computational technologies and biophysics

The company specializes in developing precision medicines aimed at treating cancer and other serious diseases by designing therapeutics that specifically address the unique molecular features of patients' diseases. By leveraging its proprietary platform, Relay Therapeutics seeks to enhance the understanding of protein dynamics and interactions, enabling the identification of better drug candidates with improved efficacy and safety profiles.